COMMUNIQUÉS West-GlobeNewswire

Cocrystal Pharma Provides Update on Clinical Development Program Evaluating CC-31244 for Ultra-Short Treatment of Hepatitis C Virus

22/01/2019 - 14:00

- Hepatitis C program designed to develop ultra-short treatment for hepatitis C virus (HCV) consisting of CC-31244, an oral, potent, broad-spectrum non-nucleoside inhibitor, as a part of combination therapy to include [...]

Vystar® Begins Soft Launch of Vytex® Cloud Bed-in-a-Box via Rotmans

22/01/2019 - 14:00

Luxuriously soft supportive comfort, resilience and breathability Thicker mattress and the ultimate plush covering 6 sizes, 3 levels of softness World’s purest, naturally anti-microbial, odor-free and virtually allergen [...]

Tower One Announces Debt Financing and Update on Tower Deployments

22/01/2019 - 14:00

VANCOUVER, British Columbia, Jan. 22, 2019 (GLOBE NEWSWIRE) -- TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) is pleased to announce it has raised $966,300 CAD by way [...]

InspireMD Announces Results from Initial Clinical Study of The CGuard™ Embolic Prevention System (EPS) with SmartFit™ Technology

22/01/2019 - 14:00

“Initial Clinical Study of the New CGuard™ EPS MicroNet® Covered Carotid Stent: ‘One Size Fits All’” presented at the LINC 2019 Congress TEL AVIV, Israel, Jan. 22, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American [...]

PetMed Express D/B/A 1-800-PetMeds Announces Its Third Quarter Financial Results and Declares Its $0.27 Per Share Dividend

22/01/2019 - 14:00

DELRAY BEACH, Fla., Jan. 22, 2019 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended December 31, 2018. Net sales were $60.1 million for both the quarters [...]

HealthLynked signs Definitive Agreement to Acquire HCFM, Adding Significant Revenue to its Health Services Division

22/01/2019 - 14:00

NAPLES, Fla., Jan. 22, 2019 (GLOBE NEWSWIRE) -- HealthLynked Corp (OTCQB: HLYK), a leading digital healthcare business, announced today that it has entered into a definitive agreement to acquire Hughes Center for [...]

Spectral Announces Distribution Agreement for its Proprietary CRRT Machine

22/01/2019 - 14:00

TORONTO, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT) , a Phase III company developing the first treatment for patients with endotoxemic septic shock guided by a [...]

Attune Pharmaceuticals Announces Positive Phase 1 Results for ATN-249, an Oral Plasma Kallikrein Inhibitor for the Treatment of HAE

22/01/2019 - 14:00

NEW YORK, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Attune Pharmaceuticals, a biotechnology company focused on the discovery and development of novel oral small molecule therapeutics for treatment of rare diseases, today [...]

Apollomics, Inc. Strengthens Leadership with Key Hires

22/01/2019 - 13:50

Wilson W. Cheung, CPA appointed Chief Financial Officer Debra L. Thoma Vallner, PhD, MBA named Senior Vice President, Development Operations FOSTER CITY, Calif. and HANGZHOU, China, Jan. 22, 2019 (GLOBE NEWSWIRE) -- [...]

DiaMedica Therapeutics Announces Publication of a Paper, “Human Tissue Kallikrein in the Treatment of Acute Ischemic Stroke,” in the Journal Therapeutic Advances in Neurological Disorders

22/01/2019 - 13:45

MINNEAPOLIS, Jan. 22, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (NASDAQ:DMAC) announces the publication of a paper titled “ Human Tissue Kallikrein In The Treatment Of Acute Ischemic Stroke ” in the peer [...]

Orchard Announces Publication by San Raffaele-Telethon Institute for Gene Therapy of OTL-300 Clinical Data for the Treatment of Transfusion-Dependent Beta-Thalassemia in Nature Medicine

22/01/2019 - 13:30

Publication Highlights Encouraging Evidence of OTL-300’s Safety and Efficacy in Transfusion-Dependent Beta-Thalassemia Patients BOSTON and LONDON, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (NASDAQ: ORTX), a [...]

Rexahn Presents Updated Preliminary Data on RX-3117 in Pancreatic Cancer at the 2019 ASCO GI Symposium

22/01/2019 - 13:30

Overall Response Rate of 38% Observed in the First 24 Patients Who Had At Least One Scan on Treatment ROCKVILLE, Md., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical-stage [...]

Onconova Therapeutics, Inc. to Present at the NobleCON 15th Annual Investor Conference in Fort Lauderdale, FL

22/01/2019 - 13:30

NEWTOWN, Pa., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today [...]

Translate Bio Announces FDA Clinical Hold on Investigational New Drug Application (IND) for MRT5201 for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency

22/01/2019 - 13:30

LEXINGTON, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat [...]

Cytokinetics Announces Receipt of FDA Feedback Regarding Reldesemtiv in Patients With SMA

22/01/2019 - 13:30

Six Minute Walk Test Acceptable as Primary Efficacy Endpoint for Potential Registration Program SOUTH SAN FRANCISCO, Calif., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced [...]

BioCorRx Awarded NIDA Grant of Approximately $5.7 Million for BICX102, a Sustained Release Naltrexone Implant for the Treatment of Opioid Use Disorder

22/01/2019 - 13:30

ANAHEIM, CA, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, announced today [...]

TG Therapeutics Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration for Umbralisib for the Treatment of Marginal Zone Lymphoma

22/01/2019 - 13:30

Breakthrough Therapy Designation granted based on interim data from the Marginal Zone Lymphoma cohort of the UNITY-NHL trial NEW YORK, Jan. 22, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), a [...]

IRADIMED CORPORATION to Hold 2018 Fourth Quarter Financial Results Conference Call on February 6th

22/01/2019 - 13:10

WINTER SPRINGS, Fla., Jan. 22, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2018 fourth quarter financial results before the market opens on Wednesday, [...]

Voyager Therapeutics Appoints Robert Hesslein as General Counsel

22/01/2019 - 13:05

CAMBRIDGE, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today [...]